Zydus Lifesciences Ltd
NSE: ZYDUSLIFE BSE: 532321
₹1188.10
-52.50 (4.23%)
Sat, 07 Nov 2026, 11:22 pm
Market Cap (in Cr)123590.72
PE Ratio26.48
Dividend0.08
Health Technology
Pharmaceuticals: Major
24.5KZydus Lifesciences Income Statement
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.45B | 17.86B | 22.66B | 28.62B | 35.74B | 44.65B | 50.90B | 61.55B | 70.60B | 84.97B | 92.52B | 92.73B | 117.49B | 129.29B | 140.27B | 142.87B | 150.63B | 170.51B | 192.51B | 228.57B |
| Gross profit | 2.09B | 2.86B | 9.71B | 13.11B | 17.07B | 21.20B | 23.60B | 25.61B | 28.62B | 35.78B | 43.69B | 37.09B | 48.65B | 50.83B | 54.89B | 60.70B | 58.95B | 68.01B | 86.28B | 114.05B |
| Operating expenses (excl. COGS) | -441.00M | -621.00M | -6.72B | -8.68B | -10.92B | -13.63B | -15.87B | -18.10B | -21.90B | -22.49B | -23.66B | -22.47B | -26.56B | -28.81B | -35.63B | -34.41B | -34.69B | -41.09B | -43.17B | -58.05B |
| Selling/general/admin expenses, total | — | — | -6.57B | -8.50B | -10.70B | -13.45B | -15.60B | -17.80B | -21.53B | -22.16B | -24.56B | -22.15B | -26.26B | -28.49B | -35.11B | -34.02B | -34.52B | -40.73B | -42.72B | -57.47B |
| Research & development | — | — | — | — | -1.66B | -2.49B | -3.64B | -4.67B | -4.56B | -5.52B | -7.59B | -7.53B | -8.63B | -9.52B | -10.97B | -11.20B | -10.41B | -12.36B | -13.08B | -18.52B |
| Selling/general/admin expenses, other | — | — | -6.57B | -8.50B | -9.04B | -10.96B | -11.96B | -13.13B | -16.97B | -16.64B | -16.97B | -14.62B | -17.62B | -18.97B | -24.14B | -22.82B | -24.11B | -28.37B | -29.64B | -38.94B |
| Other operating expenses, total | -441.00M | -621.00M | -154.00M | -182.00M | -220.00M | -186.00M | -276.00M | -307.00M | -368.00M | -334.00M | 909.00M | -323.00M | -299.00M | -317.00M | -522.00M | -393.00M | -174.00M | -357.00M | -455.00M | -587.00M |
| Operating income | 1.65B | 2.24B | 2.99B | 4.43B | 6.15B | 7.57B | 7.73B | 7.50B | 8.38B | 13.29B | 20.03B | 14.62B | 22.09B | 22.02B | 19.25B | 26.29B | 24.26B | 26.92B | 43.11B | 55.99B |
| Non-operating income, total | 100.00M | 455.00M | 182.00M | -806.00M | -109.00M | 855.00M | 210.00M | 584.00M | 1.05B | 1.17B | 955.00M | 1.53B | 1.22B | 1.80B | -4.30B | -2.30B | 4.12B | -1.02B | 4.98B | 4.28B |
| Interest expense, net of interest capitalized | -188.00M | -267.00M | -522.00M | -858.00M | -702.00M | -587.00M | -1.70B | -1.62B | -902.00M | -679.00M | -528.00M | -631.00M | -1.11B | -1.96B | -3.33B | -1.64B | -1.20B | -1.30B | -492.00M | -993.00M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 403.00M | 722.00M | 773.00M | 293.00M | 639.00M | 1.44B | 1.91B | 2.20B | 1.95B | 1.95B | 1.11B | 1.54B | 1.74B | 2.63B | 2.20B | 1.58B | 4.45B | 6.21B | 4.96B | 8.19B |
| Non-operating interest income | 37.00M | 74.00M | 78.00M | 99.00M | 145.00M | 111.00M | 302.00M | 335.00M | 343.00M | 387.00M | 627.00M | 573.00M | 494.00M | 796.00M | 325.00M | 495.00M | 688.00M | 757.00M | 1.27B | 1.85B |
| Miscellaneous non-operating expense | 366.00M | 648.00M | 695.00M | 194.00M | 494.00M | 1.33B | 1.61B | 1.86B | 1.60B | 1.57B | 486.00M | 963.00M | 1.25B | 1.83B | 1.87B | 1.09B | 3.76B | 5.45B | 3.69B | 6.34B |
| Unusual income/expense | -115.00M | — | -69.00M | -241.00M | -46.00M | — | — | — | — | -104.00M | 370.00M | 625.00M | 586.00M | 1.13B | -3.17B | -2.24B | 874.00M | -5.93B | 518.00M | -2.92B |
| Pretax income | 1.75B | 2.70B | 3.17B | 3.62B | 6.04B | 8.43B | 7.94B | 8.09B | 9.42B | 14.46B | 20.99B | 16.15B | 23.31B | 23.82B | 14.95B | 23.99B | 28.38B | 25.90B | 48.09B | 60.27B |
| Taxes | -228.00M | -281.00M | -548.00M | -589.00M | -741.00M | -1.06B | -1.13B | -1.19B | -1.06B | -2.59B | -1.77B | -1.29B | -5.64B | -5.30B | -3.20B | -1.94B | -5.12B | -5.88B | -9.78B | -14.12B |
| Non-controlling/minority interest | -1.00M | -72.00M | -37.00M | -83.00M | -238.00M | -251.00M | -286.00M | -364.00M | -326.00M | -376.00M | -304.00M | -291.00M | -346.00M | -499.00M | -278.00M | -514.00M | -1.31B | -1.32B | -1.13B | -1.47B |
| After tax other income/expense | 0 | -5.00M | -8.00M | 82.00M | -9.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.52B | 2.34B | 2.58B | 3.03B | 5.05B | 7.11B | 6.53B | 6.54B | 8.04B | 11.48B | 19.34B | 14.90B | 17.95B | 18.49B | 11.77B | 22.02B | 22.42B | 19.65B | 38.37B | 45.26B |
| Net income | 1.52B | 2.34B | 2.58B | 3.03B | 5.05B | 7.11B | 6.53B | 6.54B | 8.04B | 11.48B | 19.34B | 14.88B | 17.76B | 18.49B | 11.77B | 21.34B | 18.07B | 19.60B | 38.59B | 45.26B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.52B | 2.34B | 2.58B | 3.03B | 5.05B | 7.11B | 6.53B | 6.54B | 8.04B | 11.48B | 19.34B | 14.88B | 17.76B | 18.49B | 11.77B | 21.34B | 18.07B | 19.60B | 38.59B | 45.26B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.43B | 3.06B | 3.96B | 5.54B | 7.49B | 8.84B | 9.31B | 9.35B | 8.73B | 16.16B | 22.95B | 18.35B | 27.48B | 28.01B | 26.22B | 32.98B | 31.39B | 34.14B | 50.75B | 65.15B |
| EBIT | 1.65B | 2.24B | 2.99B | 4.43B | 6.15B | 7.57B | 7.73B | 7.50B | 6.72B | 13.29B | 20.03B | 14.62B | 22.09B | 22.02B | 19.25B | 26.29B | 24.26B | 26.92B | 43.11B | 55.99B |
| Total operating expenses | -12.80B | -15.61B | -19.67B | -24.20B | -29.59B | -37.08B | -43.17B | -54.05B | -62.22B | -71.69B | -72.49B | -78.11B | -95.40B | -107.27B | -121.02B | -116.58B | -126.37B | -143.59B | -149.40B | -172.58B |
| Prepaid expenses | 49.00M | 20.00M | 0 | 0 | 0 | 134.00M | 132.00M | 163.00M | 273.00M | 265.00M | 281.00M | 467.00M | 574.00M | 805.00M | 761.00M | 908.00M | 721.00M | 1.02B | 1.02B | 1.14B |
| Deferred income, current | — | — | — | — | — | — | — | — | 157.00M | 263.00M | 336.00M | 660.00M | 403.00M | 499.00M | 487.00M | 432.00M | 489.00M | 719.00M | 726.00M | 729.00M |
| Capital and operating lease obligations | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 145.00M | 161.00M | 161.00M | 198.00M | 321.00M | 321.00M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 1.29B | 1.33B | 1.46B | 1.67B | 1.55B | 1.57B | 1.84B | 2.09B | 961.00M | 2.42B | 2.01B | 1.16B | 2.82B | 2.52B | 2.10B | 1.20B | 1.54B | 1.94B | 4.46B | 5.13B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 7.00M | 142.00M | 194.00M | 228.00M | 392.00M | 669.00M | 904.00M | 1.19B | 1.44B | 1.69B | 1.36B | 1.56B | 1.91B | 12.93B | 13.35B | 19.37B | 20.54B | 21.73B | 22.72B | 24.05B |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -377.00M | -373.00M | -509.00M | -547.00M | -597.00M | -1.01B | -1.27B | -1.52B | -1.53B | -2.35B | -6.89B | -3.94B | -10.00M | -4.31B | -8.57B | -15.00M | -3.72B | -2.67B | -6.21B | -3.02B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
